News|Articles|June 20, 2013
High Potency APIs Video
A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.
Advertisement
A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers
2
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
3
Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands
4
Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing
5